Center for Klinisk Metabolisk Forskning

Publikation

Publikationer pr. år 2015 2020 2021 2022 2023

• 141 Tidsskriftartikel
• 67 Konferenceabstrakt til konference
• 19 Review
• 16 Ph.d.-afhandling
• 15 Mere
  • 5 Konferenceabstrakt i tidsskrift
  • 3 Letter
  • 2 Bidrag til bog/antologi
  • 2 Kommentar/debat
  • 1 Bog
  • 1 Leder
  • 1 Patent

Publikationer pr. år

Publikationer pr. år

Søgeresultater

• 2023

  Endocrine and metabolic responses to alcohol exposure in men: Unfolding physiology, pathophysiology, and therapeutic potential of fibroblast growth factor 21

  Lanng, A. R., 10 feb. 2023

  Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling
• 2022

  Bariatric surgery as a scientific tool to discover metabolic physiology and treatment targets

  Hagemann, C. A., 17 mar. 2022

  Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling

• Bile acid malabsorption: characterisation, diagnosis and treatment

  Kårhus, M. L., 10 maj 2022

  Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling

• Curcumin for the treatment of steatosis and prevention of prednisolone-induced insulin resistance

  Hellmann, P. H., 30 aug. 2022

  Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling

• Effects of exogenous glucose-dependent insulinotropic polypeptide in patients with type 1 diabetes

  Heimbürger, S. M., 20 jan. 2022, University of Copenhagen.

  Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling

• Elucidating hepatic metabolic actions of glucagon

  Rix, I., 16 sep. 2022

  Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling

• Glucose-dependent insulinotropic polypeptide receptor antagonist studies in patients with type 2 diabetes

  Stensen, S., 27 jun. 2022

  Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling

• Glucose metabolism, bone homeostasis and inflammation in adults with atopic dermatitis

  Gether, L., 10 jun. 2022

  Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling
• 2021

  Glucometabolic characterisation of totally pancreatectomised patients

  Baekdal, M., 4 okt. 2021, University of Copenhagen.

  Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling

• The effect of GLP-1 receptor agonism on metabolic deterioration in women with women with previous gestational diabetes mellitus - does it make a difference?

  Andersen, E. S., 10 dec. 2021

  Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling
• 2020

  Elucidation of the pathophysiological consequences of hyperglucagonaemia in patients with type 2 diabetes using a glucagon receptor antagonist.

  Hædersdal, S., 29 jun. 2020

  Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling

• Gluco-metabolic studies in totally pancreatectomised patients

  Juel, C., 23 okt. 2020

  Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling

• Hypoglycaemia, cardiac arrhythmias and cardiac function in type 2 diabetes

  Andersen, A., 30 nov. 2020

  Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling

• Maturity onset diabetes of the young and the incretin hormones

  Christensen, A. S., 7 sep. 2020

  Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling

• The MAG1C Study (Meal-time administration of exenatide for glycaemic control in type 1 diabetic cases. A randomised, placebo-controlled trial).

  Johansen, N. J., 18 aug. 2020

  Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling
• 2019

  Separate and combined effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 in overweight/obese men with and without type 2 diabetes

  Bergmann, N. C., 2019

  Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling